Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Going for regular eye exams is crucial for detecting diabetic retinopathy early, where treatment is the most effective. It is ...

An SMU professor and his students are collaborating with Vermont's Applied Research Associates to develop "microrobots" to ...

Usha (name changed), 62, was experiencing sudden and painless loss of vision in the right eye for one day when she turned up ...

Ocular adverse reactions reported by greater than or equal to 1% of patients in the two combined 3-year clinical trials following injection ... eye irritation (8%), vitreous detachment (7% ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...